MalarVx

Biotechnology, Health Care, Pharmaceutical
Founded in 2012-01-01
Seattle, Washington, United States
http://www.malarvx.com/
For Profit

About MalarVx

MalarVx is a bio-pharmaceutical company that develops a safe, affordable, effective malaria vaccine using innovative new technologies. The company focuses on the development of in vitro culture systems for the malaria parasite which will lead to the development of an effective whole-parasite vaccine. They collaborate with researchers in non-profit institutions, university infectious disease programs, foundations committed to solving diseases of the third world, and for-profit pharmaceutical and medical devices companies.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue:
  • Total Funding: 110000 USD
  • Last Funding: 110000 USD (Seed)
  • Funding Status: Seed

Technology Stack

MalarVx actively uses None products in their tech stack.

Market Presence

Industries: Biotechnology, Health Care, Pharmaceutical

Headquarters: Seattle, Washington, United States